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Abstract
TFAM is a DNA binding protein that activates transcription at the two major promoters of
mitochondrial DNA — the light strand promoter (LSP) and heavy strand promoter 1 (HSP1).
Equally important, it coats and packages the mitochondrial genome. TFAM has been shown to
impose a U-turn on LSP DNA, but whether this distortion is relevant at other sites is unknown.
Here, we present crystal structures of TFAM bound to HSP1 and to nonspecific DNA. In both,
TFAM similarly distorts the DNA into a U-turn. Yet, TFAM binds to HSP1 in the opposite
orientation from LSP explaining why transcription from LSP requires DNA bending, whereas
transcription at HSP1 does not. Moreover, the crystal structures reveal dimerization of DNA-
bound TFAM. This dimerization is dispensable for DNA bending and transcriptional activation,
but important in DNA compaction. We propose that TFAM dimerization enhances mitochondrial
DNA compaction by promoting looping of the DNA.
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INTRODUCTION
TFAM (transcription factor A, mitochondrial) is a multi-functional DNA binding protein
that is essential for transcriptional activation and mitochondrial DNA (mtDNA)
organization1, 2, 3, 4. As a sequence-specific transcription factor, TFAM plays a central role
in production of transcripts from the light strand promoter (LSP) and the heavy strand
promoter 1 (HSP1) of the mitochondrial genome. In in vitro transcription assays, normal
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levels of transcripts from LSP and HSP1 require TFAM5, 6. These mitochondrial transcripts
encode for 13 essential components of the respiratory chain, and therefore TFAM is
necessary for energy production from oxidative phosphorylation1, 3. In addition, TFAM is
required for maintenance of mtDNA, because truncated transcripts from LSP are used to
prime DNA synthesis during mtDNA replication. Consistent with these functions, mice
lacking TFAM have impaired mtDNA transcription and inability to maintain mtDNA,
resulting in bioenergetic failure and embryonic lethality7.
We and others have previously solved the crystal structure of TFAM bound to LSP8, 9. The
TFAM binding site at LSP is 22 base pairs long and is composed of two half-sites (Fig. 1A,
B). TFAM contains two HMG (high mobility group)-box domains (HMG-box A and HMG-
box B) that each intercalates into the minor groove of a half-site. Each intercalation
contributes to distortion of the DNA, resulting in a dramatic U-turn of the LSP sequence
(Fig. 1C). Between the two HMG-box domains is a helical linker with a positively charged
surface that interacts with the negatively charged backbone of the DNA. The C-terminal tail
of TFAM is required for activation of the transcriptional machinery. In the TFAM/LSP
structure, the carboxyl terminal HMG-box B domain binds to the half-site distal from the
transcriptional start site. Because the C-terminal tail is adjacent to HMG-box B, the U-turn
in the LSP DNA enables the C-terminal tail to contact the transcriptional machinery.
Consistent with this idea, TFAM mutants that are deficient in DNA bending are inactive for
transcriptional activation at LSP8. In contrast, the same mutants are fully active at HSP1.
Based on sequence comparisons, TFAM has been suggested to bind to HSP1 in the reverse
orientation compared to LSP10, 11. We proposed that in this reverse orientation, the C-
terminal tail would be located near the half-site adjacent to the transcriptional machinery,
rendering DNA bending unnecessary8. However, this model hinges on the expectation that
the TFAM is indeed reversed on HSP1 compared to LSP, an idea that lacks experimental
evidence.
TFAM has an equally important function in organization of the mitochondrial genome.
Located in the mitochondrial matrix and lacking histone-related proteins, mtDNA is
organized into compact mtDNA/protein structures termed nucleoids12, 13. TFAM is one of
the most abundant proteins of the nucleoid14, 15 and is thought to coat the entire
mitochondrial genome and compact it16, 17. Based on the TFAM/LSP structure, it is
tempting to assume that TFAM also imparts a U-turn when bound nonspecifically to
mtDNA. In this manner, TFAM would shorten the apparent length of the mitochondrial
genome by coating it and imposing regular sharp bends. The structurally unrelated HU
family of proteins also imparts U-turns onto DNA and may play an analogous role in the
architecture of procaryotic genomes18, 19. However, it is unclear whether the structure of
TFAM bound to LSP, where it binds in a sequence-specific mode, serves as a good model
for TFAM coating the mitochondrial genome, where it functions as a nonspecific DNA
binding protein. Although TFAM bends DNA at LSP, it has been suggested that such rigid
DNA bends are not applicable when TFAM is bound to nonspecific DNA20. Moreover, it
remains to be determined whether DNA bending is a sufficient mechanism to account for
the dramatic condensation of mtDNA within a nucleoid compared to naked circular DNA.
In this study, we present additional crystal structures of TFAM bound to HSP1 and to
nonspecific mtDNA, and show that in both cases TFAM imposes a U-turn on the DNA. We
experimentally confirm that TFAM binds HSP1 in the opposite orientation compared to the
TFAM/LSP structure and provide evidence that this orientation difference underlies the
different requirements of the two promoters for DNA bending. In the four existing TFAM
structures, we observe dimerization of TFAM via the same protein-protein interface. We
show that dimerization is not needed for DNA bending or transcriptional activation, but is
necessary for full compaction of DNA. These results suggest that TFAM dimerization
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provides an additional compaction mechanism beyond DNA bending to help organize
mtDNA into nucleoids.
RESULTS
Comparison of TFAM bound to specific and nonspecific DNA
We previously solved the crystal structure of TFAM bound to its cognate binding site on
LSP8 (Fig. 1A–C). This structure indicates that TFAM imposes a U-turn on LSP DNA upon
binding, but the generality of this observation is unknown. It is unclear whether the TFAM/
LSP structure is representative of how TFAM binds to HSP1, where DNA bending by
TFAM is dispensable for transcriptional activation8. Even more important, it is unclear
whether TFAM also imparts a U-turn when it binds nonspecific mtDNA, where it is thought
to play an important role in DNA packaging. To address these issues, we generated crystal
structures of TFAM bound to HSP1 mtDNA and non-specific mtDNA.
Our initial attempt to generate such structures yielded small and poorly diffracting crystals.
Because the TFAM/LSP structure indicates that the last 9 residues of TFAM are
disordered8, 9, we repeated crystallization trials with a new TFAM construct (residues
43-237) lacking these disordered residues. We obtained well-diffracting crystals of TFAM
bound to a 22 bp double-stranded DNA fragment from HSP1 (Fig. 1D; termed the TFAM/
HSP1 structure). This DNA fragment contains the TFAM binding site determined by
DNAse I footprinting21. In addition, we crystallized TFAM in complex with a 22 bp
fragment from the ATPase6 gene as an example of TFAM binding nonspecifically to
mtDNA (Fig. 1E; termed the TFAM/nonspecific DNA structure). Both the TFAM/HSP1 and
TFAM/nonspecific DNA structures were solved by molecular replacement using the
coordinates of TFAM/LSP9 as the search model. The structures of TFAM/HSP1 and TFAM/
nonspecific DNA were solved at a resolution of 2.9 Å and 2.8 Å, respectively. For both, the
final electron density maps were of sufficient quality to visualize all the protein residues and
the entire DNA fragment. Model building and refinement led to final Rwork and Rfree values
of 22.55% and 26.53% for TFAM/HSP1, and 21.37% and 26.11% for TFAM/nonspecific
DNA. Details of the crystallographic analyses are presented in Table 1.
The TFAM/HSP1 and TFAM/nonspecific DNA structures are highly similar to TFAM/
LSP8, 9. Superimposition against the TFAM/LSP structure generates RMSD values of 1.056
Å for TFAM/HSP1 and 0.951 Å for TFAM/nonspecific DNA (Fig. 1F). In each case, TFAM
binding imposes a full U-turn on the DNA. This U-turn is caused by the wedging of the two
HMG-box domains of TFAM into the minor groove of the DNA. Each HMG-box domain
consists of three helices that are arranged in an L-shaped configuration stabilized by
hydrophobic interactions (Fig. 1C–E). The concave surface of each HMG-box domain
intercalates into the DNA minor groove, with contributions from Leu58 and Ile81 of HMG-
box A and Asn163, Pro178, and Leu182 of HMG-box B (Fig. 1C–E, Supplementary Fig. 1).
Analysis of DNA parameters indicates that distortion of the DNA double helix is maximal at
the bases contacted by Leu58 and Leu182 (Fig. 1G). A helical linker with a positively
charged surface connects the two HMG-box domains and packs against the overlaying
DNA8, 9. As originally described for TFAM/LSP, the two intercalating HMG-box domains
and the linker, acting as a pivot, work in concert to impart a U-turn on the bound DNA.
TFAM imposes a U-turn regardless of mtDNA sequence
Taken together, these crystal structures indicate that TFAM bends DNA into a U-turn,
whether bound specifically to LSP or HSP1, or bound nonspecifically to a random mtDNA
fragment. To determine whether this DNA distortion also occurs in solution, we used an
established FRET-based assay to measure DNA bending8. To construct the FRET sensor,
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Cy3 (donor) and Cy5 (acceptor) fluorophores were covalently attached to opposite ends of
the LSP, HSP1, and ATPase6 (nonspecific) DNA fragments. Addition of TFAM to the
labeled, double-stranded DNA resulted in a dose-dependent increase in acceptor emission
and a decrease in donor emission. Control experiments confirmed that the acceptor emission
depended on the presence of both the donor fluorophore and TFAM. For each DNA
fragment, the maximal FRET efficiency corresponds to a calculated distance of 59 Å
between the DNA ends, in good agreement with the distances in the crystal structures
(TFAM/LSP: 54.7 Å; TFAM/HSP1: 53.7 Å; TFAM/nonspecific DNA: 52.9 Å; Fig. 1F, H).
These data indicate that all three DNA templates are bent to a similar degree by TFAM,
suggesting that the formation of U-shaped DNA is relevant not only in transcriptional
activation, but also in mtDNA packaging.
Reverse binding orientations of TFAM to LSP and HSP1
Based on DNA sequence analysis of the promoters, TFAM has been proposed to bind in
opposite orientations on LSP versus HSP110, 11. This idea has implications about the
mechanism of transcriptional activation by TFAM, and therefore it is important to obtain
direct experimental support. To unambiguously assign the orientation of the DNA sequence
in the TFAM/HSP1 structure, we substituted thymine at position 550 with bromo-uracil
(Fig. 2A, B). This substitution uniquely labels HSP1 DNA at the half-site proximal to the
transcriptional initiation site. Bromine has significant anomalous scattering signal, and X-
ray data from isomorphous crystals showed an anomalous peak (>5σ) at the expected
position for bromine adjacent to the HMG-box B domain (Fig. 2C, D). These data confirm
that TFAM binds HSP1 with HMG-box B occupying the proximal half-site, the orientation
opposite that found in the TFAM/LSP complex.
We analyzed the interaction of TFAM to the DNA bases in each of the three structures
(Supplementary Fig. 2). Interestingly, the TFAM/LSP structure shows several additional
base contacts that are absent in the TFAM/HSP1 and TFAM/nonspecific DNA structures.
These additional contacts, mediated by Gln179 and Arg157, may explain why TFAM makes
a robust, discrete DNAse I footprint on LSP DNA21. We did not observe additional base
contacts in TFAM/HSP1 compared to TFAM/nonspecific DNA. DNAse I footprinting
studies indicate that TFAM has lower specificity for HSP1 relative to LSP. At TFAM
concentrations that result in protection of the HSP1 site, the surrounding DNA is also
coated21.
We used in vitro transcription reactions with LSP or HSP1 templates to test the idea that
different structural features of TFAM are required for activation of these promoters.
Transcription from the LSP and HSP1 promoters can be reconstituted in vitro by providing
the DNA templates with mitochondrial RNA polymerase (mtRNAP), TFB2M, and TFAM5.
We previously generated a mutant (L6) that contained point mutations (K136A, H137A,
K139A, R140A, K146A, and K147A) in the helical linker connecting the two HMG-box
domains of TFAM8. This mutant showed the most severe DNA bending defect from a panel
of mutants. Like other DNA bending mutants, L6 is defective in activating transcription
from LSP (Supplementary Fig. 6B). However, this mutant is able to activate transcription at
HSP1 as effectively as wild-type TFAM8 (Fig. 3B, C).
To probe the basis for this defect, we asked whether HSP1 could be converted into a
promoter that is sensitive to DNA bending by TFAM. In the first approach, we reversed the
TFAM binding site at HSP1, so that HMG-box B would now bind at the distal half-site (Fig.
3A, EP1 template). In the second approach, we replaced the TFAM binding site in HSP1
with the corresponding region from LSP, again forcing TFAM to bind in a reverse
orientation compared to native HSP1 (Fig. 3A, EP2 template). When tested with in vitro
transcription assays, both these modified HSP1 promoters are activated by wild-type TFAM.
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However, the bending defective L6 mutant shows a several-fold decrease in transcriptional
activation (Fig. 3B, C).
Dimerization of TFAM
Along with the two new TFAM structures reported here, there are now four structures of
TFAM bound to DNA. Remarkably, all the structures reveal dimerization of TFAM
stabilized by an identical dimer interface. In each case, the dimer interface occurs between
HMG-box A of two separate TFAM molecules. HMG-box A consists of three helices
arranged in an L-shape, with helix 3 forming the long edge. Fig. 4A shows the interface
found within the asymmetric unit of TFAM/HSP1. The convex surfaces of two HMG-box A
domains come into contact, with helix 3 from each domain paired in an antiparallel manner
(Fig. 4A). The antiparallel interface shows a series of polar and electrostatic interactions
mainly mediated by residues Lys95, Tyr99, Glu106, Glu112, and Arg116 of helix 3 (Fig.
4B). In the helix 3/helix 3 interface, Lys95 forms a salt bridge with Glu112, and Tyr99
forms a hydrogen bond with Arg116. Between helices 3 and 1, Arg116 interacts with Glu63,
and Glu106 interacts with Arg59. With over 30 residues involved, the dimer interface has a
total buried surface area of approximately 1179 Å2 (Supplementary Fig. 1B). In the TFAM/
LSP 22 bp9, TFAM/LSP 28 bp8, and TFAM/nonspecific DNA structures, the generation of
symmetry mates from the asymmetric unit reveals identical, antiparallel helical interfaces
that superimpose well onto the interface found in TFAM/HSP1 (Fig. 4C). This interface is
unrelated to the C-terminal region previously proposed as a candidate dimerization motif17.
TFAM dimerization is not required for DNA bending or transcriptional activation
To test the physiological function of dimerization, we generated a TFAM mutant with five
substitutions (K95A, Y99F, E106A, E112A and R116A; hereafter termed “dimer mutant”)
designed to disrupt polar and electrostatic interactions at the interface. These 5 residues in
the dimerization interface are conserved in mammals (Supplementary Fig. 3). To assess
TFAM dimerization, we developed a FRET-based assay to measure TFAM/TFAM contact.
We covalently labeled TFAM molecules with either a donor fluorophore (Alexa Fluor 488)
or an acceptor fluorophore (Alexa Fluor 595) using cysteine-maleimide3 chemistry at the
single cysteine residue at position 49 (Fig. 4A), which is close to the dimer interface. In the
absence of DNA, no FRET was detected between the two labeled populations (red trace,
Fig. 5A). However, in the presence of DNA, we found a decrease in donor emission and an
increase in acceptor emission (magenta trace, Fig. 5A). This FRET signal could be
competed off by excess unlabeled TFAM (Supplementary Fig. 4A). This FRET signal was
abolished in the dimer mutant (blue trace, Fig. 5A, Supplementary Fig. 4B), suggesting loss
of dimerization. Interestingly, the dimerization of wild-type TFAM was not only dependent
on DNA, but also on the length of the DNA. Testing a range of DNA lengths (100, 150, 200,
300, to 400 bp), we found robust TFAM dimerization only with DNA fragments ≥ 200 base
pairs (Fig. 5B).
Although defective in dimerization, the dimer mutant has normal secondary structure
(Supplementary Fig. 5) and is fully functional for DNA binding (Supplementary Fig. 6A)
and bending on LSP, HSP1, or nonspecific DNA templates (Fig. 5C). Moreover, the dimer
mutant is as efficient as wild-type TFAM in transcriptional activation from either the LSP or
HSP1 template (Fig. 5D, E). Taken together, these data suggest that dimerization is
dispensable for both DNA bending and transcriptional activation.
DNA bending and TFAM dimerization are required for efficient DNA compaction
In addition to transcriptional activation, the other major function of TFAM is mtDNA
compaction. In the latter function, TFAM is thought to interact with mtDNA in a global,
nonspecific manner. To analyze the ability of TFAM mutants to compact DNA, we utilized
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a tethered particle motion (TPM) assay (Fig. 6A), in which the contour lengths of single
DNA molecules are measured upon interaction with TFAM22, 23. In this assay, one end of a
DNA molecule is attached to a bead, and the other end is immobilized onto a slide. Because
the DNA molecule has a defined length, the tethered bead will have a characteristic radius of
motion that can be quantified as a root-mean-square (RMS) value. Addition of TFAM to the
system reduces the radius of motion by decreasing the end-to-end length of the DNA tether,
a reflection of DNA compaction (Fig. 6A). Using a 1910 base pair DNA tether, we found
progressively lower RMS values with increasing TFAM concentrations (Fig. 6B). The naked
DNA tether had an RMS value of 295 nm; this value was reduced to 164 nm under
saturating TFAM concentrations (1 μM). By testing a panel of DNA lengths ranging from
539 bp to 1910 bp, we found that TFAM at saturating concentration reduces the apparent
lengths proportionally to the original length of the tether (Fig. 6C). To compare these DNA
compaction effects, we generated a DNA calibration curve for naked DNA (Supplementary
Fig. 7A). This calibration curve allowed us to convert RMS values in the presence of TFAM
to apparent DNA length, and thereby calculate the extent of compaction in terms of base
pairs (Supplementary Fig. 7B). Regardless of the original DNA length, TFAM shortened the
DNA contour-length by 64–73% (Fig. 6D)
This level of DNA compaction exceeds the maximal shortening that can be accounted for by
DNA bending and prompted us to examine the structural basis for DNA compaction in the
TPM assay. In the TFAM crystal structures, a 22 bp DNA fragment is shortened by ~50%
due to formation of a U-turn. Multiple regions of TFAM are important for bending
mtDNA8, 9, including both HMG-box domains and the intervening helical linker. Using the
1910 bp DNA tether, we compared the compaction abilities of TFAM mutants previously
established as having a DNA bending defect8. While wild-type TFAM compacted DNA
molecules to 164 nm, TFAM truncation mutants containing either HMG-box A alone or
HMG-box B alone shortened DNA to only 212 nm and 227 nm, respectively (Fig. 6E). The
linker region of TFAM coordinates the spacing and orientation of the two HMG-box
domains and is important for DNA bending. The L6 linker mutant also shows a defect in
DNA compaction. Hence both HMG-box domains as well as the intervening linker are
necessary to achieve efficient DNA compaction. This result is not surprising, given that an
important aspect of DNA compaction should be the formation of DNA U-turns.
To examine whether TFAM dimerization might affect DNA compaction, we tested the
dimer mutant in the TPM assay. We found that the dimer mutant has a substantial defect in
DNA compaction, with an RMS value of 193 nm (Fig. 6E). This DNA compaction defect is
not due to loss of DNA binding, because the mutant binds to DNA with the same affinity as
wild-type TFAM (Kd ~6–7 nM, Supplementary Fig. 6A) and has no defect in either DNA
bending or transcriptional activation (Fig. 5C–E). These results therefore uncover TFAM
dimerization as an important aspect of DNA compaction.
DISCUSSION
Our study provides several important insights into the structural biology of TFAM. First, by
providing additional TFAM structures, we show that TFAM imposes a U-turn on mtDNA
whether it is bound at LSP, HSP1, or nonspecific DNA. Therefore, extreme DNA bending is
a constitutive feature of TFAM binding. It has been suggested that DNA U-turns may not be
relevant when TFAM is bound to nonspecific DNA20. However, we show that TFAM
mutants defective in bending have a reduced ability to compact nonspecific DNA. Second,
we provide evidence that the different orientations of the TFAM binding sites at LSP
compared to HSP1 underlie the different sensitivities of these promoters to the DNA
bending activity of TFAM (Fig. 7A, B). At LSP, the C-terminal tail is oriented away from
the transcriptional start site, and a U-turn in the DNA is required to bring the C-terminal tail
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in contact with the transcriptional machinery (Fig. 7A). At HSP1, we directly confirmed by
bromine-labeling that the TFAM orientation is reversed. This new orientation places the C-
terminal tail close to the transcriptional machinery and negates the need for DNA bending
(Fig. 7B). This model is further supported by promoter engineering experiments where we
converted HSP1 into a DNA-bending-dependent promoter by reversing the TFAM
orientation. Finally, we found that the four existing TFAM/DNA structures show
dimerization of TFAM with an identical interface formed by HMG-box A/HMG-box A
interactions. In our previous study, we ignored this interface as a potential crystal-packing
artifact, but its presence in four independent structures makes this explanation unlikely.
Using a FRET assay, we detected a TFAM-TFAM interaction that is strictly dependent on
the presence of DNA. Analysis of the dimer mutant indicates that dimerization is not
required for DNA bending or transcriptional activation at LSP or HSP1. However, the
TFAM dimer mutant shows substantially reduced DNA compaction in a TPM assay. Taken
together, these results suggest that specific structural features of TFAM are critical
depending on the specific function. At LSP, DNA bending at the promoter is central to
transcriptional activation, whereas at HSP1, this feature is dispensable. TFAM dimerization
plays a key role in mtDNA compaction but not in transcriptional activation.
A recent study showed that single TFAM molecules can extensively slide over nonspecific
DNA20. Some sliding monomers of TFAM were observed to collide with immobile TFAM
multimers and aggregate into patches. Combined on our crystallographic analysis, it appears
that even though TFAM enforces a severe bend on nonspecific DNA, it can nevertheless
slide long distances. During transcription, this sliding may allow the RNA polymerase to
migrate through TFAM-coated mtDNA. In future work, it will be interesting to determine
whether the TFAM multimers utilize the dimerization motif we have identified.
Our results suggest that two factors--DNA bending and TFAM dimerization--are involved in
mtDNA compaction. In the TFAM/DNA structures, the formation of a U-turn compresses
the 22 base-pair recognition sequence by ~50% end-to-end. This extreme DNA bending
requires spatial coordination of the tandem HMG-box domains by the helical linker. TFAM
variants containing a single HMG-box domain or mutations in the helical linker show
defective DNA bending and, in the TPM assay, reduced DNA compaction. Although DNA
bending is clearly important, it alone cannot account for the 64–73% compaction that we
observed in the TPM assay. Based on the behavior of the dimer mutant, this additional
compaction appears to require TFAM dimerization. Given that the TPM assay measures the
effective length of individual DNA tethers, this dimerization occurs between TFAM
molecules bound to a single DNA fragment. TFAM dimerization in solution is only
observed with DNA templates ≥200 base-pairs in length, probably because dimerization of
TFAM molecules bound on the same DNA fragment would lead to DNA looping (Fig. 7C),
a phenomenon that is constrained by the persistence length of DNA. In contrast, under the
high protein/DNA concentrations used for crystallography, dimerization was observed
between TFAM molecules bound to separate, short DNA fragments. Some other DNA
looping proteins have been reported to condense DNA to a much greater extent24, 25 than we
have found for TFAM. It is likely that the TFAM dimerization is weak, and at equilibrium,
there is a balance between dimerization and dissociation that results in a moderate degree of
compaction from this mechanism.
It should be noted that the type of dimerization implied by our results is distinct from the
dimerization suggested in previous studies. Some studies have suggested that TFAM binds
to a single DNA binding site as a dimer17, 26. This mode of binding is unlikely given the
multiple crystal structures showing that the TFAM binding sites identified by DNAse I
footprinting are fully occupied by a single TFAM molecule. The idea that a TFAM
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monomer binds to DNA is further supported by multi-angle light scattering8 and single
molecule measurements20.
These findings clarify the mechanism for mtDNA packaging by TFAM. One aspect involves
iterations of mtDNA bending caused by coating of the genome by TFAM. Measurements in
tissues16, 27 and cells28, 29 suggest that TFAM is abundant enough to fully coat the
mitochondrial genome. Moreover, recombinant TFAM can coat nonspecific DNA in vitro
with an occupancy of one molecule per ~30 bp20, close to the theoretical maximum based on
a minimal TFAM binding site of 22 bp. The repeated application of DNA bending would
cause significant shortening of the end-to-end length of a DNA molecule. This condensed
DNA molecule can be further compacted by TFAM dimerization, which would result in
looping of the DNA between bound sites. Dimerization can only occur between TFAM
molecules spaced the appropriate distance apart. In principle, the 16 kb mtDNA genome is
long enough to accommodate many potential loops. However, in our dimerization assay, we
do not observe a linear increase in the FRET signal as the DNA length is increased,
suggesting that there may be unknown constraints. Interestingly, atomic force microscopy
images of DNA compacted in vitro by TFAM show formation of DNA loops consistent with
this model17.
MATERIALS AND METHODS TFAM
purification and labeling
Full-length, mature human TFAM (43-246), TFAM lacking the last 9 residues (43-237), and
mutants were expressed and purified as hexahistidine fusion proteins8. The hexahistidine tag
was removed with thrombin cleavage. The proteins were further purified by gel filtration
chromatography using a Hi-load Superdex 200 16/60 column (GE Healthcare) pre-
equilibrated with running buffer (20 mM Tris-HCl, 300 mM NaCl, 1 mM DTT, pH 7.5) in
an AKTA Purifier (Amersham). The protein was concentrated to 20 mg/ml and stored at
−80°C.
To obtain fluorescently labeled TFAM, recombinant TFAM (43-237), containing only a
single reactive cysteine at position 49, was incubated with either Alexa Fluor 488 maleimide
or Alexa Fluor 595 maleimide (Molecular Probes)30. The protein was dialyzed in buffer (50
mM HEPES, pH 7.5, 350 mM NaCl), diluted to 0.1 mM, and treated with 0.5 mM TCEP
(tris(2-carboxyethyl)phosphine) for 90 minutes at 4°C to ensure reduction of cysteine
residues. The labeling reaction was carried out using a six-fold excess of Alexa Fluor
maleimide for 15 h at 4°C and stopped by 3 mM DTT. Unreacted dye was removed with a
15 cm desalting column (Sephadex G-25 Medium, GE Healthcare). The concentration of
labeled protein was determined by absorbance of Alexa Fluor 488 (3495 = 73,000 M−1cm−1)
and Alexa Fluor 595 (3590 = 92,000 M−1cm−1). The labeling efficiency (moles of labeled
protein/moles of total protein) was typically ≥ 95%.
Crystallization and structure determination
The duplex HSP1 DNA was generated by mixing complementary oligonucleotides: 5′-
GGTT550GGTTCGGGGTATGGGGTT; 5′-AACCCCATACCCCGAACCAACC. The
nonspecific mtDNA template was generated by mixing complementary oligonucleotides: 5′-
ATTCAACCAATAGCCCTGGCCG; 5′-CGGCCAGGGCTATTGGTTGAAT. For the
bromine derivative of the HSP1 duplex, thymine 550 of HSP1 was substituted with bromo-
uracil (5′-GGT/i5Br-dU/GGTTCGGGGTATGGGGTT) (Integrated DNA Technologies, San
Diego) and annealed with its non-labeled complementary strand.
To form the TFAM (43-237)/HSP1 or TFAM (43-237)/HSP1-Br complexes, 0.57 mM
TFAM was mixed with 0.65 mM duplex DNA in a 1:1 volume ratio, incubated at room
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temperature for 30 min, and then on ice for 2 h. Crystallization trials by hanging drop-vapor
diffusion at room temperature identified conditions (12% PEG8000, 22% glycerol, 0.04 M
KH2PO4, pH 6.0) that yielded plate-shaped crystals. To form the TFAM (43-237)/
nonspecific DNA complex, 0.57 mM TFAM was mixed with 0.65 mM duplex DNA in a 1:1
volume ratio, incubated at room temperature for 30 min, and then on ice for 3 h. For
crystallization trials, the protein/DNA complex was mixed with reservoir solution in a
1.2:0.8 volume ratio. The complex was crystallized by hanging drop-vapor diffusion at room
temperature (9% PEG1500 and 18% glycerol), yielding plate-shaped crystals.
Crystals were flash-frozen in liquid nitrogen, and diffraction data of both native and bromo
derivative crystals were collected on beamline 12-2 at the Stanford Synchrotron Radiation
Lightsource (SSRL). The data set from the TFAM/HSP1-Br crystal was collected at the Br-
absorption peak (0.9196 Å). To avoid radiation damage, diffraction data from a second
TFAM/HSP1-Br crystal was collected at native wavelength (1.0332 Å), and this diffraction
data set was used for the final refinement. A crystal of the TFAM/nonspecific DNA complex
was collected at 0.9795 Å. All data were processed with IMOSFLM31 or XDS32 and merged
using SCALA33 as implemented in CCP4. The two structures were solved by molecular
replacement using the coordinates of the TFAM/LSP crystal structure9. The electron density
map revealed clear density for the protein and DNA. The bromine derivative of TFAM/
HSP1 yielded anomalous signal that allowed unambiguous assignment of the DNA
sequence. Manual model building was done in COOT34, and refinement of the best solutions
was carried out using REFMAC34 and PHENIX35 with an initial round of rigid body
refinement followed by a round of simulated annealing and individual B-factor refinement.
After a few rounds of model adjustment and refinement with TLS obtained from the
TLSMD server36, the Rwork converged to 22.11% and Rfree to 26.74% for TFAM/HSP1-Br,
and 21.37% and 26.11% for TFAM/nonspecific DNA. A stereo image of a portion of the
final electron density is provided in Supplementary Fig. S8. The final models include
residues 43-237 of TFAM, and all the nucleotides have excellent stereochemistry as
assessed by MolProbity37. The Ramachandran plots reveal 94.1% and 97.9% allowed
regions with no outliers for TFAM/HSP1-Br and TFAM/nonspecific DNA respectively.
Analyses of the helical parameters of the DNA molecules were carried out using 3DNA38.
Structural superimpositions and figures were prepared with Chimera 1.5.239, COOT34,
PyMol40, and 3DDART41, and NUCPLOT42.
FRET experiments for DNA bending
To generate the LSP, HSP1, and nonspecific DNA templates, the following complementary
oligonucleotides were annealed as described above: LSP: 5′/Cy3/-
TGTTAGTTGGGGGGTGACTGTTAAAAGT; 5′/Cy5/-
ACTTTTAACAGTCACCCCCCAACTAACA; HSP1: 5′/Cy3/-
GGTTGGTTCGGGGTATGGGGTT; 5′/Cy5/-AACCCCATACCCCGAACCAACC;
Nonspecific: 5′/5Cy5/-ATTCAACCAATAGCCCTGGCCG; 5′/5Cy3/-
CGGCCAGGGCTATTGGTTGAAT. Annealing reactions were performed with a small
excess of acceptor labeled DNA relative to donor labeled DNA (1.2:1 molar ratio) to ensure
that all donor-labeled DNA had a paired acceptor DNA strand43. For FRET analysis8,43,
measurements were recorded on a FluoroMax-3 spectrofluorimeter (Jobin–Yvon–Horiba) at
room temperature. Protein was titrated into a cuvette containing either 10 nM Cy3-labeled,
Cy5-labeled, or Cy3-Cy5-labeled DNA in binding buffer [20 mM Tris (pH 7.5), 150 mM
NaCl, 1 mM DTT]. For all the mutants, the protein titrations were carried out to at least 10-
fold in excess of the Kd for DNA binding. Excitation wavelengths for Cy3 and Cy5 are 525
nm and 625 nm, respectively; emission wavelengths are 562 nm and 662 nm. For Cy3- or
Cy3-Cy5-labeled DNA, scans were recorded using excitation at 525 nm and emission from
540 to 750 nm. For Cy5-labeled DNA, scans were recorded with excitation at 625 nm and
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emission from 640 to 750 nm. Slit widths for excitation and emission were 4 and 10 nm,
respectively.
The FRET efficiency (E) was calculated with the following formula:
, where Fcorr= [F - (χDD)- (χAA)]/σA and Dcorr = D/σD. Fcorr=
corrected FRET fluorescence; Dcorr= corrected fluorescence from donor alone; D= donor
fluorescence; A= acceptor fluorescence; χD= donor bleed-through coefficient; χA= acceptor
coefficient. σA and σD are measured correction factors for acceptor and donor fluorescence,
as defined below. In FRET measurements, the signals due to donor bleed-through (χD) and
direct excitation of acceptor (χA) need to be corrected. χD and χA were determined by using
the DNA fragment labeled with only a single fluorophore. To determine χD, Cy3-labeled
DNA was excited at 525 nm, and emissions were collected at 562 nm (D) and 662 nm (F).
χD = (F/D). To calculate χA, Cy5-labeled DNA was excited at 525 nm (F) or 625 nm (A),
and emissions were collected at 662 nm. χA = (F/A). We also corrected for changes in
fluorescence intensity between the unbound and bound species. For the donor signal, the
correction factor σD was calculated by dividing the donor signal of bound DNA (b) by the
donor signal of unbound DNA (u) using Cy3 labeled DNA. σD = Db/Du. For the acceptor
signal, σA was calculated by dividing the acceptor signal of bound DNA by the acceptor
signal of unbound DNA using Cy3-Cy5-labeled DNA. σA = Ab/Au. The distance (R)
between donor and acceptor pairs was calculated from the following equation: E=R06/
(R06+R6), where E=FRET efficiency and R0 = 54 Å.
FRET measurements to detect dimerization
To detect dimerization of TFAM through the HMG-box A domain, Cys49 in HMG-box A
was labeled with either Alexa Fluor 488 or Alexa Fluor 595 (see above). Fluorescence
measurements were recorded on a FluoroMax-3 spectrofluorimeter (Jobin–Yvon–Horiba) at
room temperature [20 mM Tris–HCl (pH 7.5), 150 mM NaCl and 1 mM DTT]. 400 nM
Alexa Fluor 595-labeled protein was added to 100 nM Alexa Fluor 488- labeled protein in
the presence and absence of DNA. DNA tested included fragments of various lengths (100,
150, 200, 300, and 400 bp) and circular plasmid (4 kb). When the experiment was performed
with DNA, 10 nM of linear DNA, or 1 nM of circular plasmid DNA was added to the
mixture containing both TFAM labeled with Alexa Fluor 488 and Alexa Fluor 594. The
acceptor fluorescence signal could be chased off with excess non-labeled wild-type protein.
The signal was monitored by excitation at 480 nm, and emission spectra were recorded from
494 to 690 nm. Slit widths for excitation and emission were 4 and 10 nm, respectively.
In vitro transcription reactions
DNA fragments corresponding to LSP (positions 1–477) and HSP1 (positions 499–741) of
human mtDNA were cloned into the pSP65 vector at the BamHI and SalI sites. EP1 was
constructed by reversing the TFAM binding site at HSP1, and EP2 was made by subcloning
the TFAM binding site from LSP into HSP1. LSP: 5′-A454AAT
AATGTGTTAGTTGGGGGGTGACTGTT AAAA421; HSP1: 5′-T528 GCT
AACCCCATACCCCGAACCAACC AAAC557; EP1: 5′-T528 GCT
TGGTTCGGGGTATGGGGTTAGC AAAC557; EP2: 5′-T528GCT
AATGTGTTAGTTGGGGGGTGACTGTT AAAC557. The engineered promoters were
synthesized by PCR with the appropriate oligonucleotides and cloned into the pSP65 vector
at the BamHI and SalI sites. After digestion with BamHI for LSP and SalI for HSP1
derivatives, the linearized plasmids were used as templates in a transcriptional run-off
assay8. Transcription reactions were performed in a total volume of 20 μL [10 mM HEPES
(pH 7.5), 10 mM MgCl2, 1 mM DTT, 100 μg/mL BSA, 400 μM ATP, 150 μM rCTP, 150
μM rGTP, 15 μM rUTP (Promega), 0.2 μM [α-32P] rUTP (3,000 Ci/mmol, Perkin Elmer),
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7.5 nM template DNA, and 40 units of RNaseOut (Invitrogen)]. Reactions were carried out
at 33°C by incubating the template DNA with buffer for 5 min, then subsequently adding
TFAM (100 nM), TFB2M (30 nM, Enzymax), and POLRMT (30 nM, Enzymax), with 1
min incubations between each addition. After addition of rNTPs, the reaction was incubated
for 3 h at 33°C and stopped by addition of 25 μL of stop buffer (80% formamide, 10 mM
EDTA, pH 8.0, 0.025% xylene cyanol, 0.025% bromophenol blue). Samples were heated to
90°C for 5 min and separated on 5% polyacrylamide gels containing 8 M urea in 1xTBE.
The gels were fixed in 7% acetic acid, dried, and exposed to a phosphorimager screen. The
data were collected on a Storm 880 phosphorimager (Molecular Dynamics) and quantified
using ImageQuant 5.2 Software.
Tethered particle motion assays
The tethered particle motion (TPM) assay22, 23 was used to measure DNA compaction. Non-
sequence specific DNA molecules of different lengths (539, 736, 946, 1124, 1316, 1521,
1717, and 1910 bp) were assembled in a flow cell between a glass surface and a bead. These
DNA molecules were immobilized by attaching the 5′-digoxigenin-labeled DNA to a glass
surface coated with anti-digoxigenin (Roche Diagnostics). The other end of the DNA was
attached to a 490 nm streptavidin-coated polystyrene bead (Bangs Laboratories) via a 5′-
biotin label. The flow cell surface was passivated with acetylated-BSA and casein to prevent
the DNA, beads and protein of interest from sticking. The motion of the bead was recorded
through a brightfield microscope at 30 frames per second using a Basler A602f camera. Fits
were performed using custom Matlab routines44. At least 20 single DNA tethers were
measured in buffer containing 20 mM Tris–HCl, pH 7.5, 1 mM DTT, 150 mM NaCl and
100 μg/ml A-BSA.
Circular dichroism analysis
All circular dichroism data were collected on an Aviv 62DS spectrometer with a 1-mm path
length cell. The protein sample of wild-type TFAM and the dimer mutant was 10 μM in 20
mM Tris-HCl (pH 7.5), 300 mM NaCl, and 1 mM DTT. Far-UV circular dichroism spectra
were collected at 25°C, with a data averaging time of 5 s. The data were collected every 1
nm from 195 to 260 nm.
DNA binding measurements
The TFAM DNA binding assay measures the quenching of intrinsic tryptophan fluorescence
that occurs when TFAM binds DNA. Measurements were recorded on a FluoroMax-3
spectrofluorimeter (Jobin–Yvon–Horiba) at room temperature (20 mM Tris–HCl (pH 7.5),
150 mM NaCl and 1 mM DTT). DNA was titrated into a cuvette containing 50 nM protein.
The solution was monitored by excitation at 280 nm, and emission spectra were recorded
from 320 to 380 nm. Slit widths for excitation and emission were 4 and 10 nm, respectively.
The binding data were analyzed using SigmaPlot 9.0 software.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We are grateful to the Gordon and Betty Moore Foundation and the Sanofi-Aventis Bioengineering Research
Program at Caltech for their generous support of the Molecular Observatory at Caltech. Portions of this research
were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), supported by the US NIH and DOE.
We thank Shou-ou Shan (California Institute of Technology) for use of equipment and insightful discussions, and
Jens T. Kaiser for helpful discussions about structure determination. This work was supported by NIH grants RO1
GM062967 (D.C.C.), DP1 OD000217A (Directors Pioneer Award, R.P.), and R01 GM085286 (R.P.).
Ngo et al. Page 11
Nat Commun. Author manuscript; available in PMC 2014 July 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
References
1. Bonawitz ND, Clayton DA, Shadel GS. Initiation and beyond: multiple functions of the human
mitochondrial transcription machinery. Mol Cell. 2006; 24:813–825. [PubMed: 17189185]
2. Campbell CT, Kolesar JE, Kaufman BA. Mitochondrial transcription factor A regulates
mitochondrial transcription initiation, DNA packaging, and genome copy number. Biochim Biophys
Acta. 2012; 1819:921–929. [PubMed: 22465614]
3. Falkenberg M, Larsson NG, Gustafsson CM. DNA replication and transcription in mammalian
mitochondria. Annu Rev Biochem. 2007; 76:679–699. [PubMed: 17408359]
4. Rubio-Cosials A, Sola M. U-turn DNA bending by human mitochondrial transcription factor A.
Current opinion in structural biology. 2013; 23:116–124. [PubMed: 23333034]
5. Falkenberg M, Gaspari M, Rantanen A, Trifunovic A, Larsson NG, Gustafsson CM. Mitochondrial
transcription factors B1 and B2 activate transcription of human mtDNA. Nat Genet. 2002; 31:289–
294. [PubMed: 12068295]
6. Shi Y, et al. Mammalian transcription factor A is a core component of the mitochondrial
transcription machinery. Proc Natl Acad Sci USA. 2012; 109:16510–16515. [PubMed: 23012404]
7. Larsson NG, et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and
embryogenesis in mice. Nat Genet. 1998; 18:231–236. [PubMed: 9500544]
8. Ngo HB, Kaiser JT, Chan DC. The mitochondrial transcription and packaging factor Tfam imposes
a U-turn on mitochondrial DNA. Nat Struct Mol Biol. 2011; 18:1290–1296. [PubMed: 22037171]
9. Rubio-Cosials A, et al. Human mitochondrial transcription factor A induces a U-turn structure in the
light strand promoter. Nat Struct Mol Biol. 2011; 18:1281–1289. [PubMed: 22037172]
10. Dairaghi DJ, Shadel GS, Clayton DA. Addition of a 29 residue carboxyl-terminal tail converts a
simple HMG box-containing protein into a transcriptional activator. J Mol Biol. 1995; 249:11–28.
[PubMed: 7776365]
11. Fisher RP, Topper JN, Clayton DA. Promoter selection in human mitochondria involves binding of
a transcription factor to orientation-independent upstream regulatory elements. Cell. 1987;
50:247–258. [PubMed: 3594571]
12. Bogenhagen DF. Mitochondrial DNA nucleoid structure. Biochim Biophys Acta. 2012; 1819:914–
920. [PubMed: 22142616]
13. Spelbrink JN. Functional organization of mammalian mitochondrial DNA in nucleoids: history,
recent developments, and future challenges. IUBMB Life. 2010; 62:19–32. [PubMed: 20014006]
14. Bogenhagen DF, Rousseau D, Burke S. The layered structure of human mitochondrial DNA
nucleoids. J Biol Chem. 2008; 283:3665–3675. [PubMed: 18063578]
15. Bogenhagen DF, Wang Y, Shen EL, Kobayashi R. Protein components of mitochondrial DNA
nucleoids in higher eukaryotes. Mol Cell Proteomics. 2003; 2:1205–1216. [PubMed: 14514796]
16. Alam TI, et al. Human mitochondrial DNA is packaged with TFAM. Nucleic Acids Res. 2003;
31:1640–1645. [PubMed: 12626705]
17. Kaufman BA, et al. The mitochondrial transcription factor TFAM coordinates the assembly of
multiple DNA molecules into nucleoid-like structures. Mol Biol Cell. 2007; 18:3225–3236.
[PubMed: 17581862]
18. Mouw KW, Rice PA. Shaping the Borrelia burgdorferi genome: crystal structure and binding
properties of the DNA-bending protein Hbb. Mol Microbiol. 2007; 63:1319–1330. [PubMed:
17244195]
19. Rice PA, Yang S, Mizuuchi K, Nash HA. Crystal structure of an IHF-DNA complex: a protein-
induced DNA U-turn. Cell. 1996; 87:1295–1306. [PubMed: 8980235]
20. Farge G, et al. Protein sliding and DNA denaturation are essential for DNA organization by human
mitochondrial transcription factor A. Nature communications. 2012; 3:1013.
21. Fisher RP, Clayton DA. Purification and characterization of human mitochondrial transcription
factor 1. Mol Cell Biol. 1988; 8:3496–3509. [PubMed: 3211148]
22. Finzi L, Gelles J. Measurement of lactose repressor-mediated loop formation and breakdown in
single DNA molecules. Science. 1995; 267:378–380. [PubMed: 7824935]
Ngo et al. Page 12
Nat Commun. Author manuscript; available in PMC 2014 July 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
23. Han L, et al. Concentration and length dependence of DNA looping in transcriptional regulation.
PloS one. 2009; 4:e5621. [PubMed: 19479049]
24. Skoko D, Yan J, Johnson RC, Marko JF. Low-force DNA condensation and discontinuous high-
force decondensation reveal a loop-stabilizing function of the protein Fis. Physical review letters.
2005; 95:208101. [PubMed: 16384101]
25. Skoko D, et al. Barrier-to-autointegration factor (BAF) condenses DNA by looping. Proc Natl
Acad Sci U S A. 2009; 106:16610–16615. [PubMed: 19805345]
26. Gangelhoff TA, Mungalachetty PS, Nix JC, Churchill ME. Structural analysis and DNA binding of
the HMG domains of the human mitochondrial transcription factor A. Nucleic Acids Res. 2009;
37:3153–3164. [PubMed: 19304746]
27. Ekstrand MI, et al. Mitochondrial transcription factor A regulates mtDNA copy number in
mammals. Hum Mol Genet. 2004; 13:935–944. [PubMed: 15016765]
28. Kukat C, Wurm CA, Spahr H, Falkenberg M, Larsson NG, Jakobs S. Super-resolution microscopy
reveals that mammalian mitochondrial nucleoids have a uniform size and frequently contain a
single copy of mtDNA. Proc Natl Acad Sci U S A. 2011; 108:13534–13539. [PubMed: 21808029]
29. Takamatsu C, et al. Regulation of mitochondrial D-loops by transcription factor A and single-
stranded DNA-binding protein. EMBO Rep. 2002; 3:451–456. [PubMed: 11964388]
30. Zhang X, Kung S, Shan SO. Demonstration of a multistep mechanism for assembly of the SRP x
SRP receptor complex: implications for the catalytic role of SRP RNA. J Mol Biol. 2008;
381:581–593. [PubMed: 18617187]
31. Leslie AG. Integration of macromolecular diffraction data. Acta Crystallogr D Biol Crystallogr.
1999; 55:1696–1702. [PubMed: 10531519]
32. Kabsch W. XDS. Acta CrystallogrD Biol Crystallogr. 2010; 66:125–132.
33. Evans, PR. Proceedings of the CCP4 Study Weekend. In: Sawyer, L.; Isaacs, N.; Bailey, S.,
editors. Data Collection and Processing. Warrington: Daresbury Laboratory; 1993.
34. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol
Crystallogr. 2004; 60:2126–2132. [PubMed: 15572765]
35. Adams PD, et al. The Phenix software for automated determination of macromolecular structures.
Methods. 2011; 55:94–106. [PubMed: 21821126]
36. Painter J, Meritt EA. TLSMD web server for the generation of multi-group TLS models. J Appl
Cryst. 2006; 39:109–111.
37. Davis IW, et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic
acids. Nucleic Acids Res. 2007; 35:W375–W383. [PubMed: 17452350]
38. Lu XJ, Olson WK. 3DNA: a software package for the analysis, rebuilding and visualization of
three-dimensional nucleic acid structures. Nucleic Acids Res. 2003; 31:5108–5121. [PubMed:
12930962]
39. Pettersen EF, et al. UCSF Chimera--a visualization system for exploratory research and analysis. J
Comput Chem. 2004; 25:1605–1612. [PubMed: 15264254]
40. Delano, WL. The PyMOL Molecular Graphics System. San Carlos, CA: Delano Scientific; 2002.
41. van DM, Bonvin AM. 3D-DART: a DNA structure modelling server. Nucleic Acids Res. 2009;
37:W235–W239. [PubMed: 19417072]
42. Luscombe NM, Laskowski RA, Thornton JM. NUCPLOT: a program to generate schematic
diagrams of protein-nucleic acid interactions. Nucleic Acids Res. 1997; 25:4940–4945. [PubMed:
9396800]
43. Hieb AR, Halsey WA, Betterton MD, Perkins TT, Kugel JF, Goodrich JA. TFIIA changes the
conformation of the DNA in TBP/TATA complexes and increases their kinetic stability. J Mol
Biol. 2007; 372:619–632. [PubMed: 17681538]
44. Johnson S, Linden M, Phillips R. Sequence dependence of transcription factor-mediated DNA
looping. Nucleic Acids Res. 2012; 40:7728–7738. [PubMed: 22718983]
45. McCulloch V, Shadel GS. Human mitochondrial transcription factor B1 interacts with the C-
terminal activation region of h-mtTFA and stimulates transcription independently of its RNA
methyltransferase activity. Mol Cell Biol. 2003; 23:5816–5824. [PubMed: 12897151]
Ngo et al. Page 13
Nat Commun. Author manuscript; available in PMC 2014 July 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1. Overview of the TFAM-mtDNA complexes
(A) The domain structure of mature TFAM. Residues 1–42 constitute the mitochondrial
targeting sequence that is cleaved upon import of TFAM into the mitochondrial matrix. (B)
Schematic of DNA sequences bound within TFAM crystals. Note the different orientations
of TFAM on LSP versus HSP1. The nonspecific sequence is from the ATPase6 gene. The
half-sites of LSP and HSP1 are indicated. (C), (D), (E) Side view of the TFAM/LSP,
TFAM/HSP1, and TFAM/nonspecific DNA complexes, respectively. The major
intercalating residues, Leu58 and Leu182, are highlighted. The DNA fragments are color-
coded as in (B). (F) Superimposition of TFAM crystal structures, color-coded as in (B). (G)
Comparison of roll angle values for TFAM/LSP, TFAM/HSP1, and TFAM/nonspecific
DNA. Note that there are two peaks of DNA distortion, at the positions where Leu58 and
Leu182 intercalate. (H) FRET assay for DNA bending with three different DNA templates:
LSP, HSP1, and nonspecific DNA. Data points are the average of three independent
experiments, with error bars representing standard deviations.
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Figure 2. TFAM binds HSP1 in a reverse orientation
(A) The labeled DNA template used to determine the orientation of TFAM on HSP1.
Thymine 550 was replaced with bromo-uracil to label the proximal half-site. (B) A
presentation of the 22 bp HSP1 structure, showing its U-turn shape and the location of
intercalating residues. (C) The TFAM/HSP1 complex showing location of the anomalous
signal of bromo-uracil (orange) relative to the domains of TFAM. The anomalous signal is
adjacent to HMG-box B. (D) Close-up view of the anomalous electronic density in a
Friedel-pair difference map revealing a > 5σ peak (orange).
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Figure 3. Conversion of HSP1 into a promoter dependent on DNA bending
(A) Schematic of HSP1, LSP, and two engineered promoters (EP1 and EP2) derived from
HSP1. EP1 and EP2 were designed to reverse the orientation of TFAM on HSP1. (B)
Representative transcription reactions with wild-type TFAM and the L6 mutant that is
deficient in DNA bending. (C) Quantification of transcription reactions, with error bars
representing standard deviations from three independent experiments. Values are normalized
to that of wild-type TFAM.
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Figure 4. Dimerization interface
(A) Overview of two molecules of TFAM forming a dimer in the TFAM/HSP1crystal
structure. Each TFAM molecule is bound to its own DNA fragment. Helix 3 from one
HMG-box A domain forms an antiparallel interface with the corresponding helix 3 from
another molecule. The locations of the cysteines used for protein labeling are indicated in
red. (B) Close-up of the antiparallel dimerization interface. Residues involved in hydrogen
bonds and salt bridges are labeled. (C) Superimposition of the dimerization interfaces from
all four TFAM/DNA structures: TFAM/LSP-28 bp (green, pdb:3TMM), TFAM/LSP-22 bp
(cyan, pdb:3TQ6), TFAM/HSP1-22 bp (purple), and TFAM/nonspecific DNA-22 bp (grey).
RMSD values relative to TFAM/LSP-22bp are as follows: TFAM/LSP-28 bp, 0.887;
TFAM/HSP1-22 bp, 1.056; TFAM/nonspecific DNA-22 bp, 0.951.
Ngo et al. Page 17
Nat Commun. Author manuscript; available in PMC 2014 July 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 5. Biochemical analysis of TFAM dimerization
(A) Emission spectra in a FRET assay measuring the physical interaction between TFAM
molecules. Reactions contained Alexa Fluor 488 (donor)-labeled and/or Alexa Fluor 594
(acceptor)-labeled TFAM. Fluorescence emission spectra showed FRET signal only in the
presence of plasmid DNA (magenta trace). Note that this signal was abolished in the dimer
mutant (blue trace). (B) Emission spectra of wild-type TFAM incubated with linear DNA of
varying lengths. (C) DNA bending by the dimer mutant on three templates. Data points are
the average of three independent experiments, with error bars representing standard
deviations. (D) Representative transcription assay using wild-type TFAM or the dimer
mutant. The LSP template generates a 420 nt full-length (run-off) transcript and a truncated
120 nt transcript. (E) Quantification of transcription reactions with error bars representing
standard deviations from three independent experiments.
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Figure 6. Structural determinants of DNA compaction
(A) A schematic of the TPM assay. The bead is attached by a single DNA molecule to the
glass surface. Upon addition of TFAM, the contour length of the DNA molecule is reduced,
causing a decrease in the bead’s radius of motion. (B) Effect of increasing concentrations of
TFAM on the DNA contour length. A 1910 bp DNA fragment was used. Error bars indicate
standard error of the mean from three independent experiments. (C) DNA compaction by
TFAM on DNA fragments of varying lengths. Error bars represent standard error of the
mean from three independent experiments. (D) Fractional shortening of DNA by TFAM as a
function of DNA length. (E) Maximal DNA compaction by wild-type TFAM and mutants.
A 1910 bp DNA fragment was used. Error bars illustrate standard error of the mean from
three independent experiments.
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Figure 7. Models of transcription activation by TFAM and mtDNA packaging
(A), (B) Comparison of TFAM function on LSP versus HSP1. When bound on LSP (A),
TFAM is oriented with the HMB-box B domain binding the distal half-site. As a result, the
U-turn in DNA is necessary to position the C-terminal tail (small yellow region) towards the
transcriptional machinery. The C-terminal tail is essential for transcriptional activation10 and
physically interacts with TFB2M45, but additional interactions with mtRNA polymerase are
also possible. When bound to HSP1 (B), TFAM is oriented with the HMG-box B domain
binding the proximal half-site. The C-terminal tail is positioned close to the transcriptional
machinery, and DNA bending is dispensable for transcriptional activation. (C) Model of
mtDNA compaction. Upon binding to mtDNA, each TFAM molecule imposes a local U-
turn. When TFAM coats mtDNA, the formation of multiple U-turns results in mtDNA
compaction. In addition, TFAM monomers can dimerize through the HMG-box A domain.
This interaction forms DNA loops, which further compact mtDNA in the nucleoid.
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Table 1
Data collection and refinement statistics
Data Collection TFAM/Br-HSP1 DNA(1) TFAM/Br-HSP1 DNA(2) TFAM/Nonspecific DNA
Space group P1 21 1 P1 I222
Cell dimensions
a, b, c (Å) 82.18 111.91 103.90 56.37, 82.49, 104.22 109.8, 114.38, 144.59
α, β, γ (°) 90.00 99.51 90.00 79.86, 85.48, 84.53 90, 90, 90
Resolution (Å)* 38.11-3.50 (3.69-3.50) 39.0-2.90 (3.05-2.9) 36.87 -2.81 (2.96-2.81)
aRmerge 0.107 (0.454) 0.038 (0.453) 0.084 (0.758)
I/σ I 15.3 (5.5) 13.5 (1.7) 11.9 (2.1)
Completeness (%) 98.8 (98.8) 87.1 (87.5) 97.8 (93.0)
Redundancy 10.9 (10.9) 2.0 (1.9) 3.4 (3.2)
Refinement
Resolution (Å) 2.90 2.81
No. of reflections 35532 22010
 Rwork /Rfree 0.2211/0.2674 0.2137/0.2611
 No. of Atoms 9,985 5,077
  - Protein 6,408 3,243
  - DNA 3,577 1,804
  - Water - 30
 B-factors (Å2)
  - Protein 67.0 74.2
  - DNA 78.6 98.3
  - Water - 51.8
R.M.S deviations
 - Bond lengths (Å) 0.009 0.006
 - Bond angles (°) 1.391 1.363
PDB code 4NOD 4NNU
*
Highest resolution shell is shown in parenthesis.
Note: TFAM/Br-HSP1crystal 1 was collected at the Br absorbance peak to locate Br atom and a second TFAM/Br-HSP1crystal was used to solve
the structure. Only one crystal was used to solve the TFAM/Nonspecific DNA structure.
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